Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03697096 · ClinicalTrials.gov registry record · NA
The INSPIRE-ASP UTI Trial
A NA study of Urinary Tract Infection(UTI), sponsored by Harvard Pilgrim Health Care.
- Completed
- Registry status
- NA
- Development phase
- 55,412
- Enrollment target
- 20
- Study locations
NCT03697096: Completed NA study of Urinary Tract Infection(UTI), sponsored by Harvard Pilgrim Health Care.
NCT03697096 is a NA study of Urinary Tract Infection(UTI) that has completed, run by Harvard Pilgrim Health Care. The registered enrollment target is 55,412 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (3850% higher). The trial reports 20 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03697096, a NA study of Urinary Tract Infection(UTI), has completed, sponsored by Harvard Pilgrim Health Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 55,412 participants
- Enrollment target
- 20
- Study locations
Study Summary
The INSPIRE-ASP UTI trial is a cluster-randomized controlled trial of HCA hospitals comparing routine empiric antibiotic stewardship practices with real-time precision medicine computerized physician order entry smart prompts providing the probability that a non-critically ill adult admitted with UTI is infected with a resistant pathogen. Note: that enrolled "subjects" represents 59 individual HCA hospitals that have been randomized.
Primary Outcome
The number of different extended-spectrum antibacterials received by the patient each empiric day-of-therapy (outcome measure unit), averaged over the empiric days (the first 3 days of hospitalization), summed across all participants. Note that Days-of-Therapy unit is a standardized national measure for antibacterial use in hospitals. For clarity the calculation is as follows: we define a DOT for a particular ES antibiotic as a day in which any number of doses of that antibiotic is given. Differ
Conditions Studied
Interventions
- OTHER Routine Care
- OTHER INSPIRE CPOE Smart Prompt
Study Locations (20)
Florida
- Brandon Hospital - Brandon
- Fort Walton Medical Center - Fort Walton Beach
- North Florida Regional Medical Center - Gainesville
- Osceola Regional Medical Center - Kissimmee
- Poinciana Medical Center - Kissimmee
- Lake City Medical Center - Lake City
- Largo Medical Center - Largo
- Northwest Medical Center - Margate
- Kendall Regional Medical Center - Miami
- Twin Cities Hospital - Niceville
- Putnam Community Medical Center - Palatka
- Gulf Coast Medical Center - Panama City
- Westside Regional Medical Center - Plantation
Colorado
- The Medical Center of Aurora - Aurora
- Swedish Medical Center - Denver
- Sky Ridge Medical Center - Denver
- Rose Medical Center - Denver
California
- Riverside Community Hospital - Riverside
- Regional Medical Center of San Jose - San Jose
- Los Robles Regional Medical Center - Thousand Oaks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55,412 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2024-05-16 |
| Phase | NA |
What the finished NCT03697096 record still lists
NCT03697096 is an interventional study that assigns participants to a tested intervention. Its 55,412 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (3850% higher).
The record links to 1 condition, with Urinary Tract Infection(UTI) appearing as the primary indexed condition, and to 2 interventions - of which Routine Care is the first listed.
NCT03697096 names 20 study sites across 3 states, led by Florida, Colorado, California.
Frequently Asked Questions
What is clinical trial NCT03697096 about?
NCT03697096 is a clinical study titled "The INSPIRE-ASP UTI Trial". The INSPIRE-ASP UTI trial is a cluster-randomized controlled trial of HCA hospitals comparing routine empiric antibiotic stewardship practices with real-time precision medicine computerized physician order entry smart prompts providing the probability that a non-critically ill adult admitted with UT...
What is the current status of trial NCT03697096?
This trial is currently completed. It is a NA study. The enrollment target is 55,412 participants. The study started on 2018-10-01. Estimated completion is 2024-05-16.
What conditions does trial NCT03697096 study?
This clinical trial studies the following conditions: Urinary Tract Infection(UTI).
What interventions are being tested in trial NCT03697096?
The interventions under investigation include: Routine Care (OTHER), INSPIRE CPOE Smart Prompt (OTHER).
Who is sponsoring clinical trial NCT03697096?
This trial is sponsored by Harvard Pilgrim Health Care, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03697096 being conducted?
This trial has 20 study locations across California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infection(UTI)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03697096's enrollment target sits among peer trials
55,412 7th of 2000 higher than 1,994 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07224243 · 54,000 participants · NA
Impact of Intraoperative Oxygenation Practices on Patient Outcomes
- NCT05975671 · 52,500 participants · NA
Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
- NCT06355934 · 52,121 participants
OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
- NCT00785525 · 60,000 participants · Phase 3
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI